Vertigo & vestibular disorders Board decisions

The Board granted a 100 percent disability rating for Meniere's syndrome based on the Veteran's symptoms of hearing impairment, vertigo, and cerebellar gait occurring more than once weekly.

The Board denied the veteran's request for an earlier effective date for the grant of service connection for peripheral vestibular disorder, finding that February 4, 2022 is the earliest possible effective date.

The Board granted service connection for Meniere's disease, to include as secondary to bilateral tinnitus, but denied service connection for other reactions to severe stress, major depression, to include as secondary to bilateral tinnitus.

The Board granted service connection for tinnitus and denied a compensable evaluation for bilateral hearing loss. The issues of service connection for benign paroxysmal positional vertigo and dementia (claimed as memory loss) were remanded.

The Board granted service connection for bilateral benign paroxysmal vertigo, finding that the Veteran's tinnitus is a but-for cause of his current vertigo symptomology.

The Board denied the veteran's claim for service connection for Meniere's syndrome with vertigo, finding no credible evidence of its onset during or shortly after service.

The Board granted effective dates of July 28, 2011, for the award of service connection for Meniere's disease and GERD/hiatal hernia, and June 12, 2014, for sleep apnea.

The Board denied the claim for an initial rating in excess of 70 percent for TBI with depressive disorder and alcohol abuse disorder in full sustained remission, and vertigo, for accrued benefits purposes.

The Board remands the issues of entitlement to an award of TDIU due to service-connected disabilities prior to December 31, 2008, and entitlement to an effective date prior to December 31, 2008, for the grant of eligibility for Dependents' Educational Assistance (DEA), as they are inextricably intertwined with the TDIU issue.

The Board granted service connection for Meniere's disease, finding that the Veteran's condition began during his active service.

The Board granted service connection for cervical strain, thoracic strain, right shoulder strain, benign positional vertigo, and disability manifested by shortness of breath as due to an undiagnosed illness.

The Board granted earlier effective dates for the ratings of posttraumatic headache/migraines disorder, PTSD with dyssomnia, tic disorder, and residuals of TBI, and BPPV to April 12, 2017.

The Board granted an effective date of August 8, 2022 for the award of service connection for benign paroxysmal positional vertigo (BPPV) and a total disability rating based upon individual unemployability (TDIU).

The Board granted a separate 30 percent rating for vertigo associated with the Veteran's service-connected TBI.

The Board granted service connection for headaches and an earlier effective date for a facial scar of the left eye, while denying or remanding claims for other conditions.

The Board remands the claims for service connection for benign paroxysmal positional vertigo, abnormal gait due to muscle weakness, and a rating in excess of 10 percent for a concussion (TBI) as they require further development through an adequate VA examination.

The appeal for an initial disability rating higher than 10 percent for tinnitus was dismissed, and the claim for an initial disability rating higher than 0 percent for hearing loss was denied. Several claims for service connection were remanded.

The Board granted service connection for vertigo, finding that the Veteran's vertigo began during service and has continued since service.

The appellant's claim for an increased rating for Meniere's disease is remanded to obtain a new VA examination and opinion regarding the current severity of the disability.

The Board granted service connection for residuals of a right ear ruptured tympanic membrane, to include right ear hearing loss and vertigo, but denied service connection for other conditions including right index finger pain, chronic fatigue syndrome, sinusitis, allergic rhinitis, diabetes mellitus type II, and skin disability.